Showing results (301-310 of 354) with videos related to
Sort By:
Pageof 36
Transplantation|November 10, 1998
Immunosuppressive effects and safety of a sirolimus/cyclosporine combination regimen for renal transplantationB D Kahan, J Podbielski, K L Napoli, et al.Transplantation|January 1, 1990
Proteinuria in cyclosporine-treated renal transplant recipientsA Vathsala, R Verani, L Schoenberg, et al.Clinical Nephrology|August 2, 2006
Fibromuscular dysplasia recurrence after kidney transplantation: case reportC A Benavides, Z Csapo, K Timmins, et al.Transplantation|January 1, 1992
Influence of race on crossmatch outcome and recipient eligibility for transplantationR H Kerman, P M Kimball, C T Van Buren, et al.Transplantation|July 1, 1983
The influence on pretransplant blood transfusions from random donors on immune parameters affecting cadaveric allograft survivalR H Kerman, C T Van Buren, W Payne, et al.Transplantation|September 15, 1996
Variable oral absorption of cyclosporine. A biopharmaceutical risk factor for chronic renal allograft rejectionB D Kahan, M Welsh, L Schoenberg, et al.Transplantation|April 1, 1980
Quantitation of plasma azathioprine and 6-mercaptopurine levels in renal transplant patientsS N Lin, K Jessup, M Floyd, et al.Clinical Chemistry|September 1, 1996
Sensitive and specific quantification of sirolimus (rapamycin) and its metabolites in blood of kidney graft recipients by HPLC/electrospray-mass spectrometryF Streit, U Christians, H M Schiebel, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 1, 1979
Demonstration by radionuclide imaging of possible vascular steal from a renal transplantR S Bloss, R W McConnell, B G McConnell, et al.Surgery|January 1, 1988
Complications in cardiac transplant patients requiring general surgeryR Colon, O H Frazier, B D Kahan, et al.Pageof 36